Literature DB >> 2372989

IgG subclass levels and immune reconstitution after T cell-depleted allogeneic bone marrow transplantation.

S M Kelsey1, M W Lowdell, A C Newland.   

Abstract

Defects of humoral immunity are well documented after bone marrow transplantation (BMT). Immunoglobulin recovery can be impaired and selective deficiencies of IgG subclasses have been reported. The nature of these deficiencies may reflect patterns of infection in the post-BMT period. We studied immunoglobulin and IgG subclass recovery in 20 long term (greater than 100 days) survivors of T depleted allogeneic BMT. Although there was no fall in mean levels of IgG, IgM or IgA for the patient group, 14 patients (70%) developed a deficiency of one or more immunoglobulin isotype at some stage post-BMT. Eight patients (40%) had deficiency of IgG, IgA and IgM and six had selective deficiencies. When IgG subclasses were measured it was seen that mean levels of IgG2 and IgG4 fell post-BMT with trough levels occurring at around 120 days post-transplant. Sixty per cent of patients developed IgG2 subclass deficiency and of these patients 78% had an associated IgG4 deficiency. Deficiencies of IgG1 and IgG3 were less common and less prolonged than those of IgG2 and IgG4; in addition, mean levels of IgG1 and IgG3 showed a rise early post-BMT. In conclusion, a majority of our patients developed immunoparesis following BMT, usually at around 120 days after transplantation. IgG2 subclass deficiency, often in association with IgG4 deficiency, is common and may occur despite normal total IgG levels. Deficiencies of immunoglobulin and IgG subclasses may persist for longer than 1 year post-BMT. Differing profiles of immunoglobulin and IgG subclass recovery may help dictate patterns of infection in long-term survivors of BMT.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2372989      PMCID: PMC1535212          DOI: 10.1111/j.1365-2249.1990.tb03302.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  12 in total

1.  Immunodeficiency following allogeneic bone marrow transplantation.

Authors:  R P Gale; G Opelz; M R Mickey; P R Graze; A Saxon
Journal:  Transplant Proc       Date:  1978-03       Impact factor: 1.066

2.  Does graft-versus-host disease influence the tempo of immunologic recovery after allogeneic human marrow transplantation? An observation on 56 long-term survivors.

Authors:  D R Noel; R P Witherspoon; R Storb; K Atkinson; K Doney; E M Mickelson; H D Ochs; R P Warren; P L Weiden; E D Thomas
Journal:  Blood       Date:  1978-06       Impact factor: 22.113

3.  Frequent occurrence of monoclonal gammopathies with an imbalanced light-chain ratio following bone marrow transplantation.

Authors:  L Hammarström; C I Smith
Journal:  Transplantation       Date:  1987-03       Impact factor: 4.939

4.  Analysis of late infections in 89 long-term survivors of bone marrow transplantation.

Authors:  K Atkinson; R Storb; R L Prentice; P L Weiden; R P Witherspoon; K Sullivan; D Noel; E D Thomas
Journal:  Blood       Date:  1979-04       Impact factor: 22.113

5.  Allogeneic bone marrow transplantation for adult leukaemia with soy bean lectin fractionated marrow.

Authors:  G W Slocombe; A C Newland; N W Yeatman; M Macey; H M Jones; L Knott
Journal:  Bone Marrow Transplant       Date:  1986-05       Impact factor: 5.483

Review 6.  Immunologic reconstitution after human marrow grafting.

Authors:  R P Witherspoon; L G Lum; R Storb
Journal:  Semin Hematol       Date:  1984-01       Impact factor: 3.851

7.  Serum IgG subclass concentrations in healthy adults: a study using monoclonal antisera.

Authors:  M A French; G Harrison
Journal:  Clin Exp Immunol       Date:  1984-05       Impact factor: 4.330

8.  Serum immunoglobulin levels following allogeneic bone marrow transplantation.

Authors:  C Perreault; M Giasson; M Gyger; R Belanger; M David; Y Bonny; J Boileau; R Barcelo; J P Moquin
Journal:  Blut       Date:  1985-09

9.  Long lasting IgG subclass and antibacterial polysaccharide antibody deficiency after allogeneic bone marrow transplantation.

Authors:  P Aucouturier; A Barra; L Intrator; C Cordonnier; D Schulz; F Duarte; J P Vernant; J L Preud'homme
Journal:  Blood       Date:  1987-09       Impact factor: 22.113

10.  Immunologic reactivity in marrow graft recipients receiving cyclosporine to prevent graft-versus-host disease.

Authors:  V E Von Fliedner; M Jeannet; A Gratwohl; G Pongratz; C Neri; C Nissen; M Muller; B Osterwalder; B Speck
Journal:  Transplantation       Date:  1983-08       Impact factor: 4.939

View more
  2 in total

1.  Clinical and immunological evaluation of patients with mild IgG1 deficiency.

Authors:  D A Van Kessel; P E Horikx; A J Van Houte; C S De Graaff; H Van Velzen-Blad; G T Rijkers
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

2.  Transient paraproteinemia after allogeneic hematopoietic stem cell transplantation is an underexplored phenomenon associated with graft versus host disease.

Authors:  Corinne C Widmer; Stefan Balabanov; Urs Schanz; Alexandre P A Theocharides
Journal:  Oncotarget       Date:  2017-11-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.